Global Aneurysm Coiling and Embolization Devices Markets – 2019 – 2023

The aneurysm coiling and embolization devices market will register a CAGR of over 10% by 2023.

Technological advances in aneurysm coiling and embolization devices are likely to foster the market growth in the upcoming years. Innovative devices with novel designs and concepts are expected to ensure device delivery, thrombogenicity, safety, and occlusion durability. This has further led to the development of multi-dimensional, biologically inert, complex-shaped, soft, and stretch-resistant coils in various sizes. Vendors are also increasing their R&D focus for introducing improvements in their stents, thus, driving the aneurysm coiling and embolization devices market growth during the forecast period.

Market Overview

The increasing frequency of UIAs detection

One of the growth drivers of the global aneurysm coiling and embolization devices market is the increasing frequency of UIAs detection. The improving detection of UIAs is leading to an increase in demand for neuroendovascular coiling and stenting procedures, which, in turn, is promoting market growth.

Shortage of skilled neurovascular surgeons

One of the challenges in the growth of the global aneurysm coiling and embolization devices market is the shortage of skilled neurovascular surgeons. The growing demand for neurological services and the rapidly rising geriatric population will limit the adoption of aneurysm coiling and embolization devices, which hinders the market growth.

Competitive Landscape

The market appears to be moderately fragmented with the presence of several market players. Several vendors are increasingly focusing on R&D of innovative aneurysm coiling and embolization devices. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Embolization coils – Market size and forecast 2018-2023
  • Balloon and stent-assisted coils – Market size and forecast 2018-2023
  • Access and delivery devices – Market size and forecast 2018-2023
  • Aneurysm clips – Market size and forecast 2018-2023
  • Flow diversion devices – Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America – Market size and forecast 2018-2023
  • Europe – Market size and forecast 2018-2023
  • Asia – Market size and forecast 2018-2023
  • ROW – Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Growing demand for flow diversion as an alternative to neurovascular coiling
  • Increasing focus on new product launches
  • Increasing initiatives to increase awareness of IAs

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Acandis GmbH
  • Johnson & Johnson Services, Inc.
  • Medtronic
  • Penumbra, Inc.
  • Stryker
  • Terumo Corporation

PART 14: APPENDIX

For more information about this report visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc.

Santa Casa Hospital System Chooses Carestream for a Unified Diagnostic Workflow

Santa Casa de Misericordia has selected Carestream to replace its legacy diagnostic workflow technology across all seven of its hospitals in Porto Alegre, the capital and largest city of the Brazilian state of Rio Grande do Sul.

American College of Cardiology Thanks Senators McConnell, Kaine for Efforts to Reduce Youth Tobacco...

On behalf of our patients, ACC members thank the Senators for their efforts to reduce youth tobacco use and stand ready to partner with them—and other members of Congress—to enact strong legislation establishing a federal age of 21 for the sale of all tobacco products.”

ResMed Study Finds CPAP Adherence Improved by Remote Monitoring, Self-Monitoring Across 3 Countries

ResMed reports the average adherence to PAP (positive airway pressure), the gold standard for treating sleep apnea, is approximately 50 percent when using legacy technology with no cloud connectivity or remote monitoring capabilities.

Life Image and Bialogics Analytics Partner to Enable Provider Organizations to Optimize Operations, Interoperability

The Life Image and Bialogics partnership will streamline access to analytics of medical imaging in order to help provider organizations enhance operational and financial performance, and improve patient satisfaction.

MediSpin XL™ – Cutting-Edge High-Volume Electrospinning Production Platform for Medical Devices is Launched

The launch of the MediSpin XL™ platform marks a global breakthrough in the controlled large-scale production of well-defined scaffolds for implants and membranes using fibers ranging from nanometer up to micrometer scale.

Hemodialysis Vascular Grafts Market Size Worth $276.5 Million By 2025

Increasing number of patients suffering from chronic kidney diseases (CKD) and growing adoption of biological access products due to technological advancements in the field are some of the factors contributing to revenue growth. Higher number of renal impaired patients and limited availability of suitable kidney donors are promoting hemodialysis procedures in renal impaired patients, which in turn is expected to fuel the demand for vascular grafts over the forecast period.